ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 81 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,971,862 | +106.4% | 1,978,820 | +164.7% | 1.31% | -12.4% |
Q2 2023 | $5,800,988 | +36.1% | 747,550 | 0.0% | 1.49% | -60.1% |
Q1 2023 | $4,261,035 | -3.2% | 747,550 | 0.0% | 3.74% | -9.2% |
Q4 2022 | $4,403,070 | +84.1% | 747,550 | 0.0% | 4.12% | +85.5% |
Q3 2022 | $2,392,000 | -28.6% | 747,550 | 0.0% | 2.22% | -22.0% |
Q2 2022 | $3,349,000 | -16.1% | 747,550 | 0.0% | 2.85% | +22.8% |
Q1 2022 | $3,992,000 | -63.7% | 747,550 | 0.0% | 2.32% | -62.9% |
Q4 2021 | $10,989,000 | -32.4% | 747,550 | -3.8% | 6.25% | -20.9% |
Q3 2021 | $16,251,000 | -7.8% | 777,193 | -22.0% | 7.90% | +38.0% |
Q2 2021 | $17,632,000 | -27.8% | 996,734 | 0.0% | 5.72% | -30.0% |
Q1 2021 | $24,420,000 | -48.5% | 996,734 | -28.8% | 8.17% | -18.6% |
Q4 2020 | $47,405,000 | – | 1,400,435 | – | 10.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 602,272 | $3,643,746 | 14.84% |
Column Group LLC | 3,568,181 | $21,587,495 | 14.33% |
Nextech Invest Ltd. | 4,285,714 | $25,928,570 | 7.86% |
Prosight Management, LP | 2,579,802 | $15,607,802 | 4.95% |
Invus Financial Advisors, LLC | 1,007,575 | $6,095,829 | 3.82% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,123,345 | $6,796,237 | 2.06% |
VR Adviser, LLC | 2,142,856 | $12,964,279 | 1.36% |
Altium Capital Management LP | 418,706 | $2,533,171 | 1.32% |
Euclidean Capital LLC | 1,978,820 | $11,971,862 | 1.31% |
Frazier Life Sciences Management, L.P. | 2,142,855 | $12,964,273 | 0.86% |